People thought the hardy Jatropha tree was the answer to the food vs. fuel debate, until it wasn't. Financial hard times and a misunderstanding revealed this biofuel to be like all the rest — in need of good food and water.
One third of the world's largest collection of autism-affected brain samples has been lost at McLean Hospital in Belmont, Mass.
Innovation Hub takes a look at medical procedures and devices that may change how diseases are diagnosed and treated.
There's been a hopeful development in treatment for soft-tissue sarcoma. A doctor talks about how small foundations play a crucial role in cancer research.
A couple of Cambridge companies are gaining ground with their regenerative medicine technology, which uses living cells and other natural materials to promote healing.
The life sciences entrepreneur is missing and presumed dead after a hiking accident in New Hampshire.
Scientists at Mass. General Hospital are working on a technique to strip diseased hearts of their cells and then rebuild them into healthy organs.
The battle for hepatitis C drug market dominance rages on locally, with Vertex honing its drug Telaprevir and Enanta teaming with Novartis to create a new treatment.
Some unexpected data came out of WGBH News' Super Bowl biosensor experiment that could advance a researcher's work on addiction.
While most of the tech world is analyzing Facebook’s impending IPO, a new effort at Harvard University is trying to find the next Facebook — and keep it in Cambridge.
A mid-February public hearing has been pushed back, but the public isn't keeping quiet on concerns over a center that could be studying deadly bioagents.
Paper is everywhere — in your coffeemaker, on your desk, in the recycling bin. But what if it could save lives? One Cambridge company thinks a slip of paper holds the answer to diagnosing illness cheaply, anywhere.
Mayor Menino and directors of the National Emerging Infectious Diseases Laboratories show off the safety precautions built in to protect workers and neighbors from life-threatening pathogens.
A new Boston firm has raised $34 million to develop drugs that tap into a new understanding of brown fat, a tissue that could help people burn off the more-familiar white fat.
Believe it or not, but the next big advance in treating autoimmune diseases such as multiple sclerosis and Crohn’s may be... worms.
The Secret Life Of Scientists And Engineers
The Secret Life of Scientists and Engineers
The hits and the highlights from WGBH
Stay in the know about upcoming shows, special events, discounts, and more!